PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Symptom | |diabetes |
| Sentences | 526 |
| PubMedID- 25815676 | Glucagon-like peptide-1 (glp-1) has been demonstrated to play an important role in type 2 diabetes mellitus, leading to cardiovascular diseases. |
| PubMedID- 21911774 | The need to manage the risks for cardiovascular disease associated with type 1 diabetes should be considered from childhood. |
| PubMedID- 23071607 | Type 2 diabetes is commonly associated with vascular disease, however recent findings indicate that cardiovascular complications may be initiated in the pre-diabetic state, before the diagnosis of type 2 diabetes . |
| PubMedID- 22301120 | The outcome of cardiovascular diseases in patients with diabetes is known to be better in the japanese population. |
| PubMedID- 21700920 | Identifying and removing barriers to physical activity is important because of the strong relationship between physical inactivity and cardiovascular disease in people with type 2 diabetes and the likely cardiovascular benefits for people with type 1 diabetes (5,6). |
| PubMedID- 25847351 | Recent epidemiological evidence has also shown a direct association between cognitive decline and markers of symptomatic and asymptomatic vascular disease in people with type 2 diabetes 5. |
| PubMedID- 25893104 | Another meta-analysis explored the efficacy of acei and arb in the prevention of cardiovascular disease (cvd) in patients with diabetes and hypertension.17 compared to placebo or other active treatment, in 23 studies with 32 827 patients with diabetes, acei significantly reduced the risk of all-cause mortality by 13% (rr 0.87; 95% ci 0.78 to 0.98), the incidence of cv deaths by 17% (0.83; 0.70 to 0.99), major cv events by 14% (0.86; 0.77 to 0.95), including myocardial infarction by 21% (0.79; 0.65 to 0.95) and heart failure by 19% (0.81; 0.71 to 0.93). |
| PubMedID- 22230215 | The mean egfrs, adjusted for age (continuous variable), sex, comorbid hypertension and diabetes mellitus, and history of cardiovascular diseases by multiple linear regression models, were compared between genotypes using the homozygous for the major allele as the reference. |
| PubMedID- 23536133 | Biomarker samples were collected as part of the markers and mechanisms of vascular disease in diabetes sub-study. |
| PubMedID- 23442498 | Advanced glycation end products (ages), final products of the non-enzymatic reaction between reducing sugars and amino groups in proteins, lipids and nucleic acids, promotes inflammation to accelerate the progression of vascular disease in patients with diabetes as well as other mechanisms 1. |
| PubMedID- 20334577 | Patients and methods: in 200 normoalbuminuric (<30 mg/24 h) hts 55-75 years old, without diabetes and history of coronary and cerebrovascular diseases, pearson's correlation assess the relationship between rsgfr and egfr. |
| PubMedID- 22293888 | As some studies were designed to prospectively evaluate ms and cardiovascular disease, individuals with diabetes or cardiovascular diseases were excluded from samples . |
| PubMedID- 26102958 | Objective: obesity and diabetes enhance the risk of developing cardiovascular diseases and heart failure. |
| PubMedID- 26583056 | The pathological state is defined as metabolic syndrome, which is a risk factor for diabetes and the complications of diabetic cardiac-cerebral vascular disease. |
| PubMedID- 24500563 | Despite the profound clinical importance of vascular disease in patients with diabetes mellitus, our understanding of the relative contributions of insulin resistance and hyperglycemia to atherogenesis is not complete. |
| PubMedID- 21617108 | Longer follow-up documented a significant reduction in cardiovascular disease in patients with type 1 diabetes treated with intensive glycemic control (45). |
| PubMedID- 24705616 | We further investigated the association between diabetes and different phenotypes of vascular disease in women and men (table 2). |
| PubMedID- 26083376 | Pioglitazone has shown to have beneficial effect on cardiovascular diseases in patients with type 2 diabetes mellitus . |
| PubMedID- 21517955 | Post-meal hyperglycaemia is considered a risk factor for cardiovascular disease in patients with type 2 diabetes 1. |
| PubMedID- 22748161 | Many classic and novel risk factors have been investigated to determine whether they explain the higher risk of cardiovascular disease among people with diabetes . |
| PubMedID- 26339200 | Capillary blood glucose was considered elevated at ≥5.5 mmol/l, chosen as this is commonly accepted as the threshold for pre-diabetes and increasing risk of vascular disease has been indicated above this value ; serum cholesterol levels considered to pose risk for cardiovascular disease were those above the recommended threshold of 5.5 mmol/l . |
| PubMedID- 20948832 | Other factors implicated in maldevelopment of the uteroplacental vascular connection include inherited thrombophilias and type i diabetes with vascular disease . |
| PubMedID- 26063568 | Diagnoses of malignancy, diabetes with complications, cerebrovascular disease, as well as acute and chronic renal failure were used to assess additional comorbidity. |
| PubMedID- 26219736 | Albuminuria is a strong predictor of cardiovascular disease, especially in patients with diabetes and hypertension (brantsma et al., 2006; de jong & curhan, 2006). |
| PubMedID- 21475396 | A general limitation of all perfusion techniques may arise from the presence of microvascular disease in diabetes, hypertension, and hypercholesterolemia. |
| PubMedID- 23772277 | Atherosclerotic cardiovascular disease among patients with type 2 diabetes in basrah. |
| PubMedID- 21955218 | Thrombin generation in type 2 diabetes with albuminuria and macrovascular disease. |
| PubMedID- 25532311 | C-peptide level as an early diagnostic marker of metabolic syndrome and predictor of cardiovascular disease in patients with diabetes mellitus type 2. |
| PubMedID- 24918095 | Background: dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. |
| PubMedID- 21515838 | In brief, we enrolled 2,539 patients, aged between 30 and 85 years, with type 2 diabetes and no history of cardiovascular disease. |
| PubMedID- 22116350 | The number of epidemiological studies assessing the relationship between ppg and microvascular or cardiovascular disease in subjects with diabetes is surprisingly scarce. |
| PubMedID- 22508698 | Primary and secondary prevention of cardiovascular disease in diabetes with aspirin. |
| PubMedID- 20804517 | Aims: to analyse the association between glycosylated haemoglobin a1c (hba1c) and cardiovascular disease (cvd) in patients with type 2 diabetes in the swedish national diabetes register (ndr). |
| PubMedID- 22093212 | Background: more intensive glycemic control reduces the risk of microvascular disease in patients with diabetes mellitus but has not been proven to reduce the risk of macrovascular events such as myocardial infarction and stroke. |
| PubMedID- 26207061 | Patient empowerment programme (pep) and risk of microvascular diseases among patients with type 2 diabetes in primary care: a population-based propensity-matched cohort study. |
| PubMedID- 20653327 | Therapeutic potential of aleglitazar, a new dual ppar-alpha/gamma agonist: implications for cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 26019685 | Age, race, primary renal disease, treatment modality, diabetes, history of cardiovascular disease or smoking, and hemoglobin, albumin, blood creatinine, and blood calcium levels were associated with prognosis. |
| PubMedID- 20513290 | Conclusion: cardiovascular and cerebrovascular diseases, together with diabetes were the fastest increasing ones over the past 10 years and becoming the major diseases, making the xinjiang production and construction corps an aging population. |
| PubMedID- 20431592 | We aimed this study to test the hypotheses that heart rate (hr) variability, evaluated by ambulatory blood pressure monitoring (abpm), predicts risk of incident cardiovascular disease (cvd) in patients with type 2 diabetes (t2dm). |
| PubMedID- 23810406 | Conclusion: achieving adequate control of risk factors for cardiovascular disease in patients with type 2 diabetes remains a clinical challenge. |
| PubMedID- 23913590 | Pediatric cancer survivors have increased risk of obesity, hypertension, dyslipidemia, and type 2 diabetes, leading to premature cardiovascular disease (cvd). |
| PubMedID- 24782916 | This association is worrying because diabetes doubles the risk of cardiovascular disease and cardiovascular deaths account for about 50% of deaths in people with diabetes 7. |
| PubMedID- 23028919 | Abdominal obesity; waist circumference≥90 in both genders, tlgs; tehran lipid and glucose study, egfr; estimated glomerular filtration rate,igt; impaired glucose test, ifg; impaired fast glucose, dm, diabetes, hcvd, history of cardiovascular disease, fhdm; family history of diabetes mellitus, bmi; body mass index. |
| PubMedID- 23236389 | Morbidity from diabetes is a consequence of both microvascular disease (retinopathy, nephropathy, and neuropathy) and macrovascular disease (atherosclerosis), and therefore organ dysfunctions are often inter-related. |
| PubMedID- 20860758 | Although data suggest that the control of hyperglycaemia may have a different impact on primary and secondary prevention of cardiovascular disease in patients with type 2 diabetes, in the navigator study, patients in these two groups were pooled and evaluated together (38). |
| PubMedID- 26038692 | Although diabetes mellitus is associated with increased vascular disease, it has not been described as a cause of severe pituitary hypofunction because of the protection provided by the many vessels that feed the circle of willis. |
| PubMedID- 23360385 | Previous studies have shown that morbidity and mortality from cardiovascular disease among adults with diabetes have declined in the united states . |
| PubMedID- 26239558 | This is consistent with the observation that most guidelines recommend more intense screening, especially for cardiovascular disease, in patients with diabetes . |
| PubMedID- 24158454 | The framingham stroke prediction algorithm (http://www.framinghamheartstudy.org/risk/stroke.html) included sbp values and age, diabetes mellitus, smoking, history of cardiovascular disease, presence of atrial fibrillation, left ventricular hypertrophy and the use of hypertensive medication. |
| PubMedID- 24271693 | Results suggested that cardiovascular disease patients with diabetes, particularly males, experience high rates of depression, suicide ideation, and posttraumatic stress symptoms. |